Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

The purpose of this trial was to determine cardiac toxicity and overall efficacy of the pegylated liposome doxorubicin (PLD)–docetaxel couplet alone if HER2-negative metastatic breast cancer (internal control) or with trastuzumab if HER2-positive disease. Upon central HER2 confirmation, 84 eligible...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wolff, Antonio C., Wang, Molin, Li, Hailun, Pins, Michael R., Pretorius, Florence J., Rowland, Kendrith M., Sparano, Joseph A., Davidson, Nancy E.
Format: Artigo
Sprog:Inglês
Udgivet: 2010
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3112234/
https://ncbi.nlm.nih.gov/pubmed/20333545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-0838-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker